Benefit-risk appraisal of medicines a systematic approach to decision-making /

Benefit-risk assessment is at the centre of the approval process for every new medicine. The ability to assess the risks of a new medicine accurately and to balance these against the benefits the medicine could bring is critical for every regulatory authority and pharmaceutical company. Despite this...

Full description

Saved in:
Bibliographic Details
Main Authors: Mussen, Filip.
Corporate Authors: Wiley InterScience (Online service)
Group Author: Salek, Sam.; Walker, Stuart R., 1944-
Published:
Literature type: Electronic eBook
Language: English
Subjects:
Online Access: http://onlinelibrary.wiley.com/book/10.1002/9780470748114
Summary: Benefit-risk assessment is at the centre of the approval process for every new medicine. The ability to assess the risks of a new medicine accurately and to balance these against the benefits the medicine could bring is critical for every regulatory authority and pharmaceutical company. Despite this there are very few tried and tested evaluative models currently available. The authors of this book have developed a new, pioneering tool for the assessment of benefits and risks for new medicines in development. This model utilises a multi-criteria decision analysis which involves selecting, scori.
Carrier Form: 1 online resource (x, 294 pages) : illustrations
Bibliography: Includes bibliographical references and index.
ISBN: 9780470748114
0470748117
9780470748121 (electronic bk.)
0470748125 (electronic bk.)
Index Number: RM301
CLC: R95
Contents: Concept and scope of benefit-risk evaluation of medicines -- Criteria for a benefit-risk model : a conceptual framework -- Review of the current benefit-risk assessment models -- Defining a systematic approach to decision making -- Development and application of a benefit-risk assessment model based on multi-criteria decision analysis -- A future framework for benefit-risk appraisal of medicines.